Search

Author/Creator Findeis, Mark

1. 377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects. (10th December 2020)

Authors:
Galand, Claire; Venkatraman, Vignesh; Marques, Marilyn; Strauss, James; Carvajal, Richard; Lim, Min; Morin, Benjamin; Ignatovich, Olga; Findeis, Mark; Underwood, Dennis; Dijk, Marc Van; Shapiro, Irina; Ohanjanian, Lernik; Wijatyk, Anna; Wilson, Nicholas; Buell, Jennifer; Chand, Dhan; Savitsky, Da...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A229
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects. (9th November 2020)

Authors:
Galand, Claire; Venkatraman, Vignesh; Marques, Marilyn; Strauss, James; Carvajal, Richard; Lim, Min; Morin, Benjamin; Ignatovich, Olga; Findeis, Mark; Underwood, Dennis; Dijk, Marc Van; Shapiro, Irina; Ohanjanian, Lernik; Wijatyk, Anna; Wilson, Nicholas; Buell, Jennifer; Chand, Dhan; Savitsky, Da...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A402
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search